Owing to its large population base, Asia accounts for over 35% of the estimated global incidence of Renal cell carcinoma, with China, Japan, and India collectively contributing to over a quarter of the cases.

기타 관련 콘텐츠

12/18, 2025 기사

In-Vivo CAR-T From Concept to Clinic – What It Will Take to Win the “Age of In-Vivo”

...

자세히 알아보세요